Inovox Menthol (Lidocaine Hydrochloride Monohydrate, Amylmetacresol, 2,4 Dichlorobenzyl Alcohol)

Lidocaine, the primary active ingredient, blocks voltage‑gated sodium channels on peripheral nerves. This inhibition prevents nerve depolarisation, resulting in a reversible loss of sensation in the oral mucosa, which reduces pain and discomfort during throat irritation.

The specific dose and frequency of Inovox Menthol are determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical judgment. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety of Inovox Menthol in pregnancy or lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order Inovox Menthol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Compared with simple lozenges or sprays that only provide flavour or mild soothing, Inovox Menthol combines a proven local anaesthetic (lidocaine) with antiseptic agents (amylmetacresol and 2,4‑dichlorobenzyl alcohol). This dual action offers both rapid pain relief and reduction of oral microbial load.

Inovox Menthol should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keeping the product in a cool, dry place helps maintain its stability and efficacy.

The product is applied directly to the oral mucosa, typically as a spray or lozenge, as directed by the prescriber. Patients should avoid swallowing large amounts immediately and allow the formulation to coat the affected area for optimal effect.

Serious risks include allergic reactions such as rash, angioedema, or anaphylaxis, and systemic lidocaine toxicity if excessive amounts are absorbed, which can cause dizziness, seizures, or cardiac disturbances. Any signs of severe reaction require immediate medical attention.

Individuals with a known hypersensitivity to lidocaine, amylmetacresol, 2,4‑dichlorobenzyl alcohol, or any excipients in the formulation should avoid using Inovox Menthol. Additionally, patients taking other lidocaine‑containing products or those with certain cardiac conditions should consult a healthcare professional before use.